Review

An update on palliative therapy in advanced prostate cancer

• Kaan Özdedeli
• Uğur Kuyumcuoğlu

İntravezikal tedavilere yardımcı yöntemler

• Hüseyin Cihan Demirel

Treatment of small renal masses: Where we are in 2011

• Mutlu Ateş
• Mustafa Karalar
• Engin Doğantekin

Is intravesical BCG treatment necessary and/or sufficient?

• Sinan Ekici
• Polat Türker

Comparing outcomes of external radiotherapy modalities for prostate cancer

• Şefik İğdem

Should all patients with non-muscle invaziv bladder tumor receive postoperative early single dose intravesical chemotherapy?

• Sümer Baltacı
• Ömer Gülpınar

In which fields intermittent androgen deprivation therapy can be used in 2014?

• Yasin Ceylan
• Bu¨lent Gu¨nlu¨soy

Approach to the complications of intravesical therapy in bladder cancer

• Turgay Gülecen
• Cüneyd Özkürkçügil

Recent advancements in the targeted therapy of metastatic kidney cancer

• Sertaç Yazıcı
• Halil Kızılöz
• Haluk Özen

Supportive treatment for patient receiving gemsitabine-cisplatine and suggestions for nursing

• Yeter Kırdal

Can Bladder be Preserved with TURB + Chemotherapy instead of Radical Surgery (Can we Preserve the Bladder from Cancer)

• Cavit Can

Could focal therapy in prostate cancer replace standard therapy in the future?

• Saadettin Y. Eskiçorapçı
• Cihan Toktaş

Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer

• Elif Atağ
• Aziz Karaoğlu
• Ömer Küçük

Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer

• Aziz Karaoğlu
• Utku Oflazoğlu
• Necla Demir

How should be follow-up strategy in stage 1 testicular tumor, are there any novelties?

• Yakup Kordan
• Mehmet Çağatay Çiçek

Neoadjuvant and adjuvant treatment modalities for prostate cancer

• Erkan Erkan
• Gökhan Toktaş

A New Era in Metastatic Prostate Cancer: “The Combination of Chemotherapy and Hormonal Treatment as Initial Treatment”

• İlker Tinay
• Levent Türkeri

Management of post-chemotherapy residual masses in testicular tumor and surgical tecnique

• Ferhat Ateş
• Ömer Yılmaz
• Kadir Vehbi Baykal

New chemotherapeutic approaches in testicular tumors

• Arzu Yaren
• Gamze Gököz Doğu
• Serkan Değirmencioğlu

Treatment options in low-intermediate risk prostate cancer

• Saadettin Yılmaz Eskiçorapçı
• Deniz Bolat

Immunotherapy in prostate cancer

• Murat Lekili

Are there any treatment option for metastatic prostate cancer refractory to docetaksel?

• Yaşar Bedük

Radiotherapy in low and intermediate-risk prostate cancer

• Deniz Yalman

Surgical treatment and/or radiotherapy in high risk prostate cancer

• Fatih Bıçaklıoğlu
• Cenk Acar
• Sinan Sözen

Androgene suppression therapy in addition to radical radiotherapy in high risk prostate carcinoma

• İlknur Bilkay Görken

The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?

• Polat Türker
• Levent Türkeri

Focal Therapy for Prostate Cancer: Current Status of HIFU

• Tayyar Alp Özkan
• Saadettin Eskiçorapçı

The Prostatic Urethral Lift Method: A New Minimally Invasive Modality as an Alternative in the Treatment of Benign Prostatic Hyperplasia

• Alpaslan Yüksel
• Ali Tekin

Current treatment approaches in locally advanced prostate cancer: a radiation oncologist perspective

• Ömür Karakoyun Çelik

Management of recurrences after radiation therapy used for curative intent in prostate cancer

• Yılören Tanıdır
• Levent Türkeri

Salvage radical prostatectomy for locally recurrent prostate cancer following primary radiotherapy

• Ali Cansu Bozacı
• Sertaç Yazıcı

Adjuvant and Neoadjuvant Targeted Therapies in Locally Advanced Renal Cell Carcinoma

• Ozan Bozkurt
• Ömer Demir

AUA/ASTRO 2013 Guidelines for Adjuvant and Salvage Radiation Therapy After Prostatectomy: What are the Yields and the Changes?

• Deniz Yalman

The role of surgery in renal cell carcinoma metastasis

• Levent Mert Günay
• Mehmet Cemil Uygur

‘Nanotechnology Applications’ in the Treatment of Prostate Cancer

• Ali Furkan Batur
• Kerem Gencer Kutman
• Mustafa Suat Bolat

Immunotherapy for the treatment of castration resistant prostate cancer: sipuleucel-T

• Güven Aslan

Rising Psa After Radical Prostatectomy: Radiotherapy in High Risk Group: Early? Late?

• Gül Alço
• Sefik İğdem

Postchemotherapy Retroperitoneal Lymph Node Dissection

• Burak Çıtamak
• Bülent Akdoğan
• Mesut Altan
• Haluk Özen

Nursing interventions in patients receiving Taxan Chemotherapy

• Yeter Kırdal

Most frequently seen side effects of targeted therapy: how to manage?

• Önder Kara
• Bülent Akdoğan

Current situation of the clinical stage I nonseminomatous germ cell testis tumour

• Alim Koşar
• Osman Ergün

Molecular Fundamentals of the Revolution in the Treatment of Renal Cell Carcinoma

• Ece Konaç
• Sinan Sözen

Chemotherapy related adverse events in patients with testicular cancer

• Özgür Tanrıverdi
• Bülent Karabulut

The Diagnosis and Treatment of Retroperitoneal Mass

• Ümit Gül

Testicular cancers: developments in radiotherapy

• Şefik İğdem
• Gül Alço

Targeted Therapies in Advanced Renal Cell Cancer

• Sinan Karaaslan

Cytoreductive Nephrectomy in the Targeted Treatment Era

• Özgür Yaycioglu

Molecular Biology in Diagnosis and Treatment of Prostate Cancer

• Ece Konaç
• Sinan Sözen

Phytotherapy in Benign Prostatic Hyperplasia

• Mehmet Kaynar
• Serdar Göktaş

Neoadjuvant targeted therapy in renal cell carcinoma

• Sertaç Yazıcı
• Halil Kızılöz
• Haluk Özen

Diagnostic and Prognostic Molecular Features of Urothelial Bladder Cancer and New Treatment Approaches

• Zafer Küçükodacı
• Kutsal Yörükoğlu

The Effects of Hormonal Therapy on Quality of Life in Prostate Cancer

• Yusuf Şenoğlu
• Kamil Çam

Quality of Life of Patients with Advanced/Metastatic Renal Cell Carcinoma During the Treatment Period with Targeted Drugs

• Sinharib Çitgez

Article - Comment

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

• Ali Tekin

Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: An alternative to intravesical therapy or early cystectomy?

• Murat Bozlu

Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy—a propensity scoring approach

• Cemil Uygur

• Saadettin Yilmaz Eskiçorapçi

Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.

• Kadir Türkölmez

Surgical resection of renal cell carcinoma after targeted therapy

• Asıf Yıldırım

Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer

• Ali F. Şahin

Radiation Oncology

Radiation therapy for bladder cancer

• Ömür Karakoyun Çelik
• Fatma Sert

Possible problems and solutions after radiation therapy for prostate cancer

• Serdar Özkök

Bph

Long-term treatment of Benign Prostatic Hyperplasia with the combination of alpha blockers and 5-alpha reductase inhibitors

• Cevahir Özer
• Mehmet İlteriş Tekin

General Urooncology

An approach to dermatological side effects of targeted therapies

• Cemal Bilaç
• Sedef Bayata
• Serap Öztürkcan